Supplementary materialS next-generation sequencing of mirna
Four consecutive 10 μm thick sections of each pure DCIS sample (Cohort 1) were macro-dissected and subjected to DNA/RNA extraction using AllPrep DNA/ RNA FFPE Kit (Qiagen), following the manufacturer's instructions. DNA and RNA were assayed using NanoDrop and Bioanalyzer, respectively. The short RNA was profiled using an RNAseq approach on SOLiD (Applied Biosystems). Briefly, 1 μg of total RNA for each patient was size-selected on Flashpage Fractionator (Ambion). The resulting RNA products were all under 40 nucleotides, as confirmed using the Bioanalyzer 2100 Small RNA chip (Agilent). The total RNA-Seq Kit (Applied Biosystems) was used to produce cDNA libraries as follows: 5ʹ and 3ʹ specific adapters were ligated to the RNA, the products were reverse transcribed, purified, and ran on a 6% TBEUrea gel (Invitrogen). cDNAs from gel slices between 60 and 80 nt in length were excised and used as templates in a 17-cycle PCR reaction with primers specific to the adapter sequences and including a unique barcode for each patient. The PCR reactions were purified and the 110-130 bp fragments were selected on a 6% TBE gel (Invitrogen). The cDNA libraries were then isolated by shredding the gel with elution in PAGE Elution buffer, and precipitated with 5 M ammonium acetate and isopropanol. Templated sequencing beads were produced via emulsion PCR with an Applied Biosystems' EZ Bead system. The templated sequencing beads were finally sequenced on an Applied Biosystems SOLiD 5500 system. The miRNA-Seq data were quality and adapter trimmed using trim galore (http:// www.bioinformatics.babraham.ac.uk/projects/trim_galore) which implements cutadapt (Martin, DOI: http://dx.doi. org/ 10.14806/ej.17.1.200) and FastQC (http://www. bioinformatics. babraham.ac.uk/projects/fastqc). We subsequently mapped onto miRBase v21 using NovoAlign (Novocraft Technologies).
Gene Ontology analysis of mirna expression
The correlated mRNAs to miR-126 and miR-218 were identified using Spearman correlation in the METABRIC, TCGA, UK and Norway BC cohorts, including only the samples with paired miRNA and mRNA expression. The miRNA-associated mRNAs were selected, when cross-validated in both large cohorts: METABRIC (n = 1302) and TCGA (n = 822), Benjamini-Hochberg (BH) corrected p-value <1e-4, and in at least one of the two smaller remaining cohorts: UK (n = 207) and Norway (n = 43), BH corrected p-value <0.001 and 0.05, respectively. This multi-cohort approach was performed to enable the selection of robustly correlated gene-sets across different studies, technical platforms and breast cancer cohorts. The putative targets were selected as the negatively correlated genes that had matching conserved sites to the miRNA seeds according to TargetScan vers. 7.1 (http://www. targetscan.org). To pinpoint the cellular roles of miR-126 and miR-218 in breast cancer, we performed a Gene Ontology analysis of the correlated gene sets using the Panther Classification System (http://www.pantherdb.org) and Gene Ontology (http://geneontology.org/).
